The type of reactive moiety controls the site and stability of the covalent link and also the total number of PEGylation sites on a given protein.
A. Sorina Morar, PhD
Advertisement
A. Sorina Morar, PhD, is a scientist, Process Development, Diosynth Biotechnology, 3000 Weston Parkway, Carey, NC 25713, 919.388.5649, fax: 919.678.0366, sorina.morar@diosynth-rtp.com.
Articles by A. Sorina Morar, PhD
Advertisement
Latest Updated Articles
PEGylation of Proteins: A Structural ApproachPublished: April 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress
5
